Schedule 13G ownership disclosure

OS THERAPIES INCORPORATED

Common Stock, par value $0.001 per share · CUSIP: 68764Y207

Event date: 2025-06-30

Filing-level shares
3,115,681.00
Percent of class
9.4%
  • Thomas A. Satterfield, Jr.

    Shares: 3,115,681.00 · Class: 9.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-077540
Form type
SCHEDULE 13G/A
Filer
OS Therapies Inc
CIK
CIK 1795091
Filed
Aug 13, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub